Nisa Investment Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

Nisa Investment Advisors, LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	BUY	$8.36 - $11.37 $6,470 - $8,800	774 Added 5.12%	15,890 $141,000
Q4 2022 Feb 02, 2023	SELL	$7.95 - $9.48 $85,160 - $101,549	-10,712 Reduced 41.47%	15,116 $138,000
Q3 2022 Nov 07, 2022	SELL	$6.86 - $11.95 $658,717 - $1.15 Million	-96,023 Reduced 78.8%	25,828 $208,000
Q2 2022 Aug 03, 2022	BUY	$7.38 - $10.4 $265,443 - $374,067	35,968 Added 41.88%	121,851 $916,000
Q1 2022 Apr 29, 2022	SELL	$7.33 - $9.39 $60,487 - $77,486	-8,252 Reduced 8.77%	85,883 $806,000
Q4 2021 Feb 03, 2022	BUY	$7.9 - $10.19 $743,666 - $959,235	94,135 New	94,135 $794,000
Q2 2021 Aug 06, 2021	SELL	$9.9 - $11.56 $231,066 - $269,810	-23,340 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$10.34 - $12.81 $241,335 - $298,985	23,340 New	23,340 $269,000
Q3 2020 Oct 20, 2020	SELL	$8.57 - $12.69 $637,976 - $944,681	-74,443 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$8.12 - $13.12 $604,477 - $976,692	74,443 New	74,443 $918,000
Q3 2019 Oct 17, 2019	SELL	$6.16 - $9.6 $776 - $1,209	-126 Closed	0 $0
Q2 2019 Jul 12, 2019	SELL	$8.12 - $15.72 $2,005 - $3,882	-247 Reduced 66.22%	126 $1,000
Q1 2019 Apr 17, 2019	SELL	$15.58 - $20.01 $296,331 - $380,590	-19,020 Reduced 98.08%	373 $6,000
Q4 2018 Jan 17, 2019	SELL	$14.59 - $23.84 $56,901 - $92,976	-3,900 Reduced 16.74%	19,393 $299,000
Q3 2018 Oct 16, 2018	BUY	$21.06 - $25.65 $482,695 - $587,898	22,920 Added 6144.77%	23,293 $504,000
Q2 2018 Jul 19, 2018	SELL	$16.77 - $24.71 $1,693 - $2,495	-101 Reduced 21.31%	373 $11,000
Q3 2017 Oct 13, 2017	BUY	$15.41 - $32.17 $7,304 - $15,248	474	474 $14,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.